RT Journal Article
SR Electronic
T1 Patient outcomes after hospitalisation with COVID-19 and implications for follow-up: results from a prospective UK cohort
JF Thorax
JO Thorax
FD BMJ Publishing Group Ltd and British Thoracic Society
SP 399
OP 401
DO 10.1136/thoraxjnl-2020-216086
VO 76
IS 4
A1 David T Arnold
A1 Fergus W Hamilton
A1 Alice Milne
A1 Anna J Morley
A1 Jason Viner
A1 Marie Attwood
A1 Alan Noel
A1 Samuel Gunning
A1 Jessica Hatrick
A1 Sassa Hamilton
A1 Karen T Elvers
A1 Catherine Hyams
A1 Anna Bibby
A1 Ed Moran
A1 Huzaifa I Adamali
A1 James William Dodd
A1 Nicholas A Maskell
A1 Shaney L Barratt
YR 2021
UL http://thorax.bmj.com/content/76/4/399.abstract
AB The longer-term consequences of SARS-CoV-2 infection are uncertain. Consecutive patients hospitalised with COVID-19 were prospectively recruited to this observational study (n=163). At 8–12 weeks postadmission, survivors were invited to a systematic clinical follow-up. Of 131 participants, 110 attended the follow-up clinic. Most (74%) had persistent symptoms (notably breathlessness and excessive fatigue) and limitations in reported physical ability. However, clinically significant abnormalities in chest radiograph, exercise tests, blood tests and spirometry were less frequent (35%), especially in patients not requiring supplementary oxygen during their acute infection (7%). Results suggest that a holistic approach focusing on rehabilitation and general well-being is paramount.